Medicinal Cannabis Matters: Friday Roundup - 5 December 2025
This week’s round-up brings together three areas where understanding is growing: sleep health, emerging cannabinoid research in HIV care and the role medicinal cannabis could play in chronic pain across post-industrial communities. Each story highlights a different aspect of patient wellbeing; from rest and recovery to inflammation, mood and long-term pain management. At a time when many people are seeking safer, evidence-based alternatives for ongoing symptoms, these conversations are more relevant than ever.
The “3-3-3 Rule” and the UK’s Sleep Struggle
A recent LADbible report, featuring our very own Dr Sunny Naye, explores the rising number of people experiencing sleep disruption and the growing interest in the “3-3-3 rule” as a way to manage night-time anxiety and overthinking.
While the method focuses on grounding techniques, it also highlights the scale of sleep difficulties faced across the UK with many people reporting cycles of restlessness, pain, stress and racing thoughts.
Dr Sunny Nayee regularly sees how deeply sleep affects overall wellbeing. In his clinical work, he notes that for some patients medicinal cannabis can play a role in breaking this cycle by supporting more consistent sleep patterns, easing pain that interrupts rest and reducing the physiological tension that fuels insomnia.
As increasing numbers of patients seek alternatives to sedative medication or long-term sleeping tablets, Dr Nayee has observed a growing interest in treatment pathways that address both the physical and emotional drivers of poor sleep, an area where medicinal cannabis continues to show potential when used safely and appropriately under specialist care.
Cannabinoids in HIV Care: Early Signs of Anti-Inflammatory Benefit
New analysis published by Pharmacy Times examined research into low-dose cannabinoids and their potential to rebalance serotonin levels and reduce inflammation in patients living with HIV.
The findings offer a promising insight into how cannabinoids may support the management of conditions where inflammation, mood disturbance and chronic symptoms are closely linked. This emerging evidence reinforces what many clinicians already observe: cannabinoids interact with the endocannabinoid system in ways that extend beyond symptom suppression, potentially supporting broader physiological balance.
Medicinal Cannabis Support For Post-Industrial Communities With Chronic Pain
An article from Mancunian Matters took a close look at chronic pain in post-industrial regions, areas where manual labour and long-term physical strain often collide.
This article highlights the pressing issue that thousands of people living with persistent pain may have limited treatment options beyond long-term painkillers. The discussion points to medicinal cannabis as a potential part of the solution, offering support with pain intensity, inflammation, sleep disruption and daily function.
For many patients, the benefit lies not only in pain relief but in regaining a sense of control over their lives, like being able to move, work, rest and participate more fully in day-to-day routine.
Across sleep health, inflammation research and chronic pain, more conversations are emerging about treatments that support the whole person, not just the symptom. Medicinal cannabis continues to show potential in areas where current options may be limited or difficult to tolerate.
If you are exploring alternative treatment options, the first step is to check your eligibility. The process is simple, confidential and available whether you live in the UK or the Channel Islands. You can complete the eligibility check in minutes and receive guidance from our clinical team on the next steps.
Disclaimer: This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.